NL7015376A - - Google Patents
Info
- Publication number
- NL7015376A NL7015376A NL7015376A NL7015376A NL7015376A NL 7015376 A NL7015376 A NL 7015376A NL 7015376 A NL7015376 A NL 7015376A NL 7015376 A NL7015376 A NL 7015376A NL 7015376 A NL7015376 A NL 7015376A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR6935974A FR2068412A1 (xx) | 1969-10-21 | 1969-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7015376A true NL7015376A (xx) | 1971-04-23 |
Family
ID=9041804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7015376A NL7015376A (xx) | 1969-10-21 | 1970-10-21 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3737524A (xx) |
| JP (1) | JPS502008B1 (xx) |
| BE (1) | BE757653A (xx) |
| DE (1) | DE2051745A1 (xx) |
| FR (1) | FR2068412A1 (xx) |
| GB (1) | GB1294580A (xx) |
| NL (1) | NL7015376A (xx) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT347602B (de) * | 1975-08-22 | 1979-01-10 | Fresenius Chem Pharm Ind | Mittel zur durchfuehrung eines harnsaeure- belastungstests |
| FR2353293A1 (fr) * | 1976-06-03 | 1977-12-30 | Beljanski Mirko | Polyribonucleotides ayant une activite dans la genese des leucocytes et des plaquettes sanguines |
| DE2824411A1 (de) * | 1978-06-03 | 1979-12-13 | Boehringer Sohn Ingelheim | Antiviral wirksame t-rna-praeparate |
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
| JPS59219235A (ja) * | 1983-05-30 | 1984-12-10 | Mitsui Toatsu Chem Inc | 消化性潰瘍用剤 |
| FR2598619A1 (fr) * | 1986-05-16 | 1987-11-20 | Mafitra Management Services In | Medicament antiviral a base d'acide nucleique modifie, et son procede de preparation |
| DE10065953A1 (de) * | 2000-12-23 | 2002-07-04 | Degussa | Verfahren zur Erhöhung der inneren Stabilität von Natriumpercarbonat |
| EP2600901B1 (en) | 2010-08-06 | 2019-03-27 | ModernaTX, Inc. | A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof |
| HRP20220796T1 (hr) | 2010-10-01 | 2022-10-14 | ModernaTX, Inc. | Ribonukleinske kiseline koje sadrže n1-metil-pseudouracil i njihove uporabe |
| CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP3492109B1 (en) | 2011-10-03 | 2020-03-04 | ModernaTX, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| RS63244B1 (sr) | 2011-12-16 | 2022-06-30 | Modernatx Inc | Kompozicije modifikovane mrna |
| WO2013151664A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9303079B2 (en) | 2012-04-02 | 2016-04-05 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| PL2922554T3 (pl) | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| EP3052106A4 (en) | 2013-09-30 | 2017-07-19 | ModernaTX, Inc. | Polynucleotides encoding immune modulating polypeptides |
| SG11201602503TA (en) | 2013-10-03 | 2016-04-28 | Moderna Therapeutics Inc | Polynucleotides encoding low density lipoprotein receptor |
-
0
- BE BE757653D patent/BE757653A/xx unknown
-
1969
- 1969-10-21 FR FR6935974A patent/FR2068412A1/fr not_active Withdrawn
-
1970
- 1970-10-20 US US00082556A patent/US3737524A/en not_active Expired - Lifetime
- 1970-10-21 DE DE19702051745 patent/DE2051745A1/de active Pending
- 1970-10-21 GB GB49882/70A patent/GB1294580A/en not_active Expired
- 1970-10-21 NL NL7015376A patent/NL7015376A/xx unknown
- 1970-10-21 JP JP45092115A patent/JPS502008B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US3737524A (en) | 1973-06-05 |
| BE757653A (fr) | 1971-04-16 |
| DE2051745A1 (de) | 1971-04-29 |
| FR2068412A1 (xx) | 1971-08-27 |
| GB1294580A (en) | 1972-11-01 |
| JPS502008B1 (xx) | 1975-01-23 |